Genolair (omalizumab biosimilar)
/ Generium
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
July 10, 2024
A Study of Genolair in Two Dosage Forms (Solution and Lyophilisate) and Xolair® in Healthy Volunteers
(clinicaltrials.gov)
- P1 | N=180 | Completed | Sponsor: AO GENERIUM
New P1 trial • Asthma • Immunology • Pulmonary Disease • Respiratory Diseases
1 to 1
Of
1
Go to page
1